Decentralized Trials Expand Access—but Risk Inequity - Takeaways - MDSpire

Decentralized Trials Expand Access—but Risk Inequity

Remote clinical research is proliferating fast. The field is still working out who gets left behind.

Share

1

The RESOLVE trial showed underrepresentation of Hispanic participants, highlighting inequities in decentralized trials.
2

Decentralized trials may shift participation barriers rather than eliminate them, affecting trial inclusivity.
3

Remote trials rely on technology that may disadvantage populations with lower digital fluency or access.
4

Hybrid trial models can enhance diversity by combining in-person and remote participation options.
5

Trial design must prioritize representativeness to ensure findings are generalizable across diverse populations.